These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38863339)

  • 1. Innovative Delivery System Combining CRISPR-Cas12f for Combatting Antimicrobial Resistance in Gram-Negative Bacteria.
    Long TF; Zhou SY; Huang ZL; Li G; Zhong Q; Zhang XJ; Li YY; Chen CP; Xia LJ; Wei R; Wan L; Gao A; Ren H; Liao XP; Liu YH; Chen L; Sun J
    ACS Synth Biol; 2024 Jun; 13(6):1831-1841. PubMed ID: 38863339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant
    Hao M; He Y; Zhang H; Liao XP; Liu YH; Sun J; Du H; Kreiswirth BN; Chen L
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-engineering a mobile-CRISPR/Cas9 system for antimicrobial resistance gene curing and immunization in Escherichia coli.
    He YZ; Kuang X; Long TF; Li G; Ren H; He B; Yan JR; Liao XP; Liu YH; Chen L; Sun J
    J Antimicrob Chemother; 2021 Dec; 77(1):74-82. PubMed ID: 34613377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resensitizing tigecycline- and colistin-resistant
    Zhang H; Chen B; Wang Z; Peng K; Liu Y; Wang Z
    Microbiol Spectr; 2024 Apr; 12(4):e0388423. PubMed ID: 38385691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of AMR plasmids using a mobile, broad host-range CRISPR-Cas9 delivery tool.
    Walker-Sünderhauf D; Klümper U; Pursey E; Westra ER; Gaze WH; van Houte S
    Microbiology (Reading); 2023 May; 169(5):. PubMed ID: 37226834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of bla
    Tao S; Chen H; Li N; Fang Y; Zhang H; Xu Y; Chen L; Liang W
    BMC Microbiol; 2023 Oct; 23(1):310. PubMed ID: 37884864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Transposon-Associated CRISPR/Cas9 System Specifically Eliminates both Chromosomal and Plasmid-Borne
    He YZ; Yan JR; He B; Ren H; Kuang X; Long TF; Chen CP; Liao XP; Liu YH; Sun J
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0105421. PubMed ID: 34339270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted elimination of Vancomycin resistance gene vanA by CRISPR-Cas9 system.
    Tao S; Hu C; Fang Y; Zhang H; Xu Y; Zheng L; Chen L; Liang W
    BMC Microbiol; 2023 Dec; 23(1):380. PubMed ID: 38049763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli.
    Dong H; Xiang H; Mu D; Wang D; Wang T
    Int J Antimicrob Agents; 2019 Jan; 53(1):1-8. PubMed ID: 30267758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion sequences in the CRISPR-Cas system regulate horizontal antimicrobial resistance gene transfer in Shigella strains.
    Chen S; Liu H; Liang W; Hong L; Zhang B; Huang L; Guo X; Duan G
    Int J Antimicrob Agents; 2019 Feb; 53(2):109-115. PubMed ID: 30290202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A versatile one-step CRISPR-Cas9 based approach to plasmid-curing.
    Lauritsen I; Porse A; Sommer MOA; Nørholm MHH
    Microb Cell Fact; 2017 Aug; 16(1):135. PubMed ID: 28764701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugative Delivery of CRISPR-Cas9 for the Selective Depletion of Antibiotic-Resistant Enterococci.
    Rodrigues M; McBride SW; Hullahalli K; Palmer KL; Duerkop BA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31527030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Introduced RNA-Only Approach for Plasmid Curing via the CRISPR-Cpf1 System in
    Chen BC; Chen YZ; Lin HY
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to combat antimicrobial resistance: anti-plasmid and plasmid curing.
    Buckner MMC; Ciusa ML; Piddock LJV
    FEMS Microbiol Rev; 2018 Nov; 42(6):781-804. PubMed ID: 30085063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.
    Rafiq MS; Shabbir MA; Raza A; Irshad S; Asghar A; Maan MK; Gondal MA; Hao H
    BioDrugs; 2024 May; 38(3):387-404. PubMed ID: 38605260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance.
    Mayorga-Ramos A; Zúñiga-Miranda J; Carrera-Pacheco SE; Barba-Ostria C; Guamán LP
    ACS Infect Dis; 2023 Jul; 9(7):1283-1302. PubMed ID: 37347230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of
    Wan P; Cui S; Ma Z; Chen L; Li X; Zhao R; Xiong W; Zeng Z
    Infect Drug Resist; 2020; 13():1171-1178. PubMed ID: 32368108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting a conjugative endogenous CRISPR-Cas3 system to tackle multidrug-resistant Klebsiella pneumoniae.
    Zhou Y; Yang Y; Li X; Tian D; Ai W; Wang W; Wang B; Kreiswirth BN; Yu F; Chen L; Jiang X
    EBioMedicine; 2023 Feb; 88():104445. PubMed ID: 36696817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens.
    Shabbir MAB; Shabbir MZ; Wu Q; Mahmood S; Sajid A; Maan MK; Ahmed S; Naveed U; Hao H; Yuan Z
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):21. PubMed ID: 31277669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.